Docs implant leadless pacemaker on elderly
Dharwad: The doctors at
SDM Narayana Heart Centre
in Sattur, Dharwad have successfully implanted a micra
leadless pacemaker
on a 79-year-old industrialist from Bengaluru.
Unlike conventional pacemakers that require a chest incision and wires, the leadless pacemaker is a compact, wire-free device.
The procedure was performed on the industrialist who had a history of recurrent episodes of syncope (sudden loss of consciousness) due to bradycardia (abnormally slow heart rate) caused by an AV (atrioventricular) block.
The patient had been experiencing dizziness and multiple episodes of fainting since June last year. One such incident led to a nasal bone fracture, and another resulted in a road accident while driving. Though stable upon admission, he underwent a cardiac evaluation, including ECG, ECHO, Holter monitoring, coronary angiogram and routine blood tests, before the diagnosis was confirmed.
Senior consultant cardiologist Dr Raghu Prasad S, who led the procedure, said the implantation was done using a minimally invasive approach. "The procedure requires no incision in the chest or under the skin, only a small puncture in the groin area, from where the device is implanted into the heart via a catheter inserted into the vein. It reduces the risk of complications and improves patient comfort and recovery," Dr Prasad said.
Highlighting the procedure that lasted barely 45 minutes, he said, "The leadless pacemaker was positioned and implanted directly into the right ventricle, to facilitate electrical impulses to be delivered to regulate the heart's rhythm."
The pacemaker that was inserted in the patient is a small tube-like device which is the size of two vitamin capsules and 93% smaller than a conventional pacemaker. It is a modern, minimally invasive device used to treat slow heart rhythms, he said.
The patient was discharged the next day after the procedure. He was reported to have resumed his daily routine and regular work schedule, without any discomfort.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
4 hours ago
- Hans India
Heartbeats That Matter: The Silent Risks of Heart Rhythm Disorders
As we observed World Heart Rhythm Week (June 2–8, 2025), the theme 'One Heart, Many Rhythms' underscored the importance of recognizing and addressing heart rhythm disorders, or arrhythmias. These conditions, often silent yet potentially life-threatening, are increasingly prevalent in India, necessitating heightened public awareness and proactive healthcare measures. The Silent Surge of Arrhythmias Heart rhythm disorders occur when the electrical impulses that coordinate heartbeats function improperly, causing the heart to beat too fast, too slow, or irregularly. Among these, Atrial Fibrillation (AF) is the most common, affecting over 33 million people worldwide . In India, a recent study analyzing 24-hour Holter monitor data from nearly 24,000 adults found that 17.4% had episodes of paroxysmal AF, many of which were asymptomatic and thus likely to go undetected during routine clinical visits . Demographic Disparities and Risk Factors Arrhythmias are not confined to any single demographic but show varying prevalence across different groups: Age: The incidence of AF increases with age, with individuals over 65 being particularly susceptible. Gender: While AF is more commonly diagnosed in men, women with AF have a higher risk of stroke and mortality. Studies indicate that women are less likely to receive appropriate anticoagulation (blood thinner) therapy, potentially due to under-recognition of risk . Lifestyle Factors: Conditions such as hypertension, diabetes, obesity, and lifestyle habits like smoking and excessive alcohol consumption significantly elevate the risk of developing arrhythmias. The Youth Are Not Immune Contrary to common belief, arrhythmias are increasingly being diagnosed in younger populations. In urban centers, cardiologists report a rise in arrhythmia cases among individuals in their 30s and 40s, often linked to stress, sedentary lifestyles, and metabolic disorders . Challenges in Detection and Diagnosis A significant challenge in managing arrhythmias is their often intermittent and sometimes asymptomatic nature. Short or intermittent episodes may not be captured during standard ECGs, leading to underdiagnosis. Advanced monitoring techniques, such as extended Holter monitoring and wearable devices, can improve detection rates but are not yet widely accessible in many parts of India. Bridging the Awareness Gap Awareness is the first step toward prevention and effective management. Public health initiatives should focus on: Education: Informing the public about the signs and symptoms of arrhythmias, such as palpitations, dizziness, and unexplained fatigue. Screening Programs: Implementing screening, especially for high-risk groups, to facilitate early detection. Access to Care: Improving access to specialized cardiac care and diagnostic tools across urban and rural settings. The heart's rhythm is a delicate balance, and disruptions can have serious consequences. As we marked World Heart Rhythm Week, let us commit to increasing awareness, improving detection, and ensuring timely treatment of arrhythmias. By doing so, we can help many maintain the steady beat of a healthy heart.
News18
22-05-2025
- News18
Lymphatic Drainage Massages: Hype, Healing, or Half-Truths? Doctors Weigh In
Last Updated: The lymphatic system plays a crucial role in maintaining immune defense and fluid balance in the body From glossy spa menus to viral TikTok tutorials, lymphatic drainage massages have rapidly gained popularity as a supposed shortcut to detoxing, slimming, and even boosting immunity. But are these trending treatments backed by science—or is it just another wellness fad masquerading as medical advice? Let's separate fact from fiction when it comes to lymphatic massages and the reality is more nuanced than social media would have you believe. A Vital but Misunderstood System The lymphatic system plays a crucial role in maintaining immune defense and fluid balance in the body. Unlike the circulatory system, it lacks a central pump and relies instead on movement, muscle contraction, and deep breathing to circulate lymph—a fluid that removes waste, toxins, and excess fluid from tissues. 'Your body already has a very capable detox system—your liver, kidneys, and yes, the lymphatic system," explained Dr. H. Guru Prasad, Associate Clinical Director and Head of General Medicine, CARE Hospitals, Banjara Hills, Hyderabad. 'But contrary to social media trends, you don't need costly massages to keep it functioning well." Echoing this, Dr. Siddharth M, Consultant Vascular & Endovascular Surgeon, Gleneagles BGS Hospital, Bengaluru, noted, 'While lymphatic massages have some clinical value, the majority of wellness claims made about them are exaggerated or not supported by strong medical evidence." When Are Lymphatic Massages Actually Useful? Both doctors agree that lymphatic drainage has legitimate medical applications—but only in specific contexts. 'Lymphatic massages can be helpful in managing lymphedema, which is swelling caused by fluid retention after surgery, cancer treatment, or infections that affect lymph nodes," said Dr. Prasad. 'In those cases, manual lymphatic drainage, when done under proper medical guidance, can support recovery." Dr. Siddharth added that these massages are also useful post-operatively, especially for patients who have undergone lymph node removal or experience persistent swelling. 'When performed correctly, they can reduce localized fluid retention while improving comfort and mobility," he said. Debunking the Detox and Slimming Myths A major appeal of lymphatic massages on social media is the promise of instant de-bloating or slimming. But both doctors caution against misinterpreting these short-term effects as lasting results. 'Weight loss or body contouring observed after such massages is usually the result of temporary fluid movements, not fat reduction," clarified Dr. Siddharth. 'These are transient outcomes and should not be misconstrued for long-term health benefits." Dr. Prasad called out the misleading idea that these massages act as a detox: 'There's a lot of misinformation floating around about lymphatic drainage massages being a shortcut to detox or weight loss. The truth is, your body doesn't need external help to detox—it's already equipped for that." So, What Actually Supports Lymphatic Health? Forget the spa. According to both experts, the best way to support your lymphatic system is free, simple, and rooted in daily habits. 'To naturally support lymph health, stay hydrated, include fresh fruits and vegetables in your diet, move regularly—especially walking and deep breathing exercises—and avoid sitting still for long hours," said Dr. Prasad. Dr. Siddharth added: 'Incorporating stretching, wearing compression garments if medically indicated, and elevating limbs can also enhance lymph flow, particularly in at-risk individuals." The Bottom Line: Context Is Key In the right medical setting, and when administered by trained professionals, lymphatic drainage massages can play a supportive role in treatment plans. But for the average healthy person, the spa version is unlikely to offer anything more than a relaxing hour. 'Context, technique, and realistic expectations are crucial," said Dr. Siddharth. 'It's not a miracle cure—it's a medical tool that must be used wisely." As Dr. Prasad puts it, 'Don't fall for the shortcut myth. Your body needs movement and good habits—not magic massages—to thrive." First Published: May 22, 2025, 14:15 IST
NDTV
21-05-2025
- NDTV
No More Covid Boosters For Healthy Children, Adult Americans Without New Trials
US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans. Food and Drug Administration Commissioner Marty Makary and Vinay Prasad, who leads the agency's vaccine division, outlined the approach they intend to take with updated versions of the immunizations in an article published Tuesday in the New England Journal of Medicine. The agency's willingness to continue making the shots available for high-risk people with a wide range of health conditions was a relief to the industry, which feared a wave of restrictions from President Donald Trump's political appointees who questioned the vaccines. Investors were buoyed as the new policy doesn't require the costly trials for older adults who are more likely to get vaccinated. Moderna Inc's shares rose 6.1% as of 2:51 pm in New York. Pfizer Inc gained 1.9% and Novavax Inc fell 1.6%. Jefferies analyst Michael Yee said the announcement "actually eases some investor concern." Bloomberg Intelligence analyst Sam Fazeli added that the FDA guidance "may be a silver lining" for Covid vaccine makers because it could increase use of the shots, given how many people are considered high risk. Covid vaccination rates have been in decline, with just 23% of US adults getting the latest booster, according to the Centers for Disease Control and Prevention. The article also offered a favourable take on how the agency's leaders are thinking broadly about vaccines, even as their boss, Health and Human Services Secretary Robert F Kennedy Jr, has criticised the shots. Makary and Prasad praised them in general, and immunizations for measles specifically, amid an ongoing outbreak that's led to more than 1,000 infections and three deaths this year. Required Research Typically, with seasonal vaccines like the flu, drugmakers are able to introduce new formulas designed to match the mutating virus based on simple tests that show they generate a strong immune response. These faster reviews follow initial approvals based on rigorous trials proving the shots are safe and reduce the risk of infection and death. Going forward, the FDA expects drugmakers to do full studies before it approves updated immunisations for those six months to 64 years old without health issues that put them at high risk, Makary and Mr Prasad wrote. Shots for the elderly and those with health risks, a group they say encompasses between 100 million and 200 million Americans, will be cleared using the current approach that doesn't require extensive studies. Companies likely won't need to do new trials every year, Mr Prasad said during an FDA town hall on Tuesday. Rather, he said they will probably be needed when "the virus really changes." "We have an obligation every few years - or however long that may be - to generate credible evidence for the American people, to clarify that we know where we stand," Mr Prasad said. The rigorous trials, which involve testing against a placebo, are typically considered unethical when a vaccine already exists because it involves withholding proven protection and potentially exposing people to preventable illness. Manufacturers have also worried that it may be difficult to do comprehensive studies in time to make shots available when a new strain begins circulating. The range of high-risk conditions that will allow for vaccine use without additional studies is broad, including people who are obese and have mental health conditions like depression, the FDA officials wrote. It's unclear if drug companies would do the trials to get broader approval. Moderna and Novavax didn't immediately respond to requests for comment. Pfizer is evaluating the new policy and is having ongoing discussions with the agency, a spokesperson said. The company believes "broad vaccination programs are an essential tool for helping to prevent COVID-19-associated hospitalizations and severe disease, including death," the spokesman said. New Direction Changes in who gets Covid vaccinations have been looming for some time. While the shots currently are recommended for everyone aged six months and older, a group of CDC advisers is debating whether they should only be offered to high-risk children and adults. Such a move would make it even less attractive for companies to do the additional studies. The FDA is changing its approach in part because the benefits of repeat Covid shots - particularly among low-risk people who may have already gotten boosters or been infected by the virus multiple times - is uncertain, Makary and Prasad wrote. The FDA's new policy "represents a balance of regulatory flexibility and a commitment to gold-standard science," they said. "The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at low risk." The FDA has already started to limit who can get Covid shots. Last week, the agency gave full approval to a Covid vaccine from Novavax, but for a narrower group that includes adults 65 and older and those ages 12-to-64 who have at least one underlying condition. The agency also required the company to conduct additional safety trials, including evaluating the risk of myocarditis, or inflammation of the heart muscle. Moderna, meanwhile, is currently awaiting an FDA decision on a new version of its Covid vaccine. The article didn't address the company's situation.
